Dark chocolate
Dietary SupplementMildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
NCT Number: NCT02130141
The evidence linking chocolate with lowered blood pressure has been observed. However, the interventions have been short, at most 4 weeks. The aim of this study is to find out if the habitual consumption of dark chocolate for 8 weeks has an effect on blood pressure. Also, more insight to the mechanisms linking chocolate to individual healt-responses is needed.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Interventional
Not applicable
University of Helsinki, Helsinki, Helsingin Yliopisto, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
Usual snacks are limited.
Time frame: 8 weeks
Usual daily snack is replaced by 50 g dark chocolate for a period of 8 weeks. During the control period, the same usual snack is limited in the diet, but without the replacement with the dark chocolate.
Time frame: 8 weeks
Time frame: 8 weeks
University of Helsinki
Other
The Effects of Dark Chocolate on Blood Pressure in Mildly Hypertensive Individuals
Acronym: CHOKO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06550297
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT06560034
Blood Pressure, Cardiovascular Diseases
Breckenridge, Colorado, United States
View Trial DetailsNCT05062161
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT05472454
Blood Pressure, Cardiovascular Diseases
Spokane, Washington, United States
View Trial Details